#VisualAbstract: Teplizumab improves beta-cell function in newly diagnosed type 1 diabetes
1. In this randomized controlled trial, two 12-day courses of teplizumab improved C-peptide levels compared to placebo at week 78 in patients with stage 3 type 1 diabetes. 2. No…